These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2577984)

  • 21. Influence of colon degradation of polysaccharide on the oral bioavailability of theophylline from controlled release hydrophilic matrices.
    Babu GV; Himasankar K; Kumar NR; Murty KV
    Boll Chim Farm; 2003 Dec; 142(10):454-60. PubMed ID: 14971315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
    Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
    Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacokinetics of a new fluid theophylline sustained-release drug form. Microcapsules in a sachet].
    Fuchs WS; Weiss G; von Nieciecki A; Laicher A; Gay S; Pabst G; Müller M
    Arzneimittelforschung; 1998 May; 48(5A):612-7. PubMed ID: 9676354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
    Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
    Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of channeling agents on the release pattern of theophylline from kollidon SR based matrix tablets.
    Ibn Razzak MS; Khan F; Hossain M; Khan MZ; Azad MA; Reza MS
    Pak J Pharm Sci; 2009 Jul; 22(3):303-7. PubMed ID: 19553179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of curdlan to controlled drug delivery. I. The preparation and evaluation of theophylline-containing curdlan tablets.
    Kanke M; Koda K; Koda Y; Katayama H
    Pharm Res; 1992 Mar; 9(3):414-8. PubMed ID: 1614977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo evaluation of tegaserod maleate pH-dependent tablets.
    Zhang SQ; Thumma S; Chen GH; Deng WB; Repka MA; Li SM
    Eur J Pharm Biopharm; 2008 May; 69(1):247-54. PubMed ID: 18037278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of different variables on the in vitro dissolution of a theophylline sustained-release preparation].
    Fuchs WS; Jakobs R; Grunenberg P; Weiss G; Profitlich T; von Nieciecki A; Klemm FH; Laicher A; Stanislaus F
    Arzneimittelforschung; 1998 May; 48(5A):552-6. PubMed ID: 9676343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel hydrogel system from scleroglucan: synthesis and characterization.
    Coviello T; Grassi M; Rambone G; Santucci E; Carafa M; Murtas E; Riccieri FM; Alhaique F
    J Control Release; 1999 Aug; 60(2-3):367-78. PubMed ID: 10425341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between gel structural properties and drug release pattern in scleroglucan matrices.
    Daraio ME; François N; Bernik DL
    Drug Deliv; 2003; 10(2):79-85. PubMed ID: 12746053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preparation of ondansetron hydrochloride sustained-release tablet evaluation of its and drug release behavior in vitro].
    Zhang Y; Huang G; Yu Y; Han J; Yu P
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):597-600, 614. PubMed ID: 16856397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The in vivo performance of theophylline microcapsules.
    Nixon JR; Meleka MR
    J Microencapsul; 1984; 1(1):65-72. PubMed ID: 6336516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethyl cellulose as a potential sustained release coating for oral pharmaceuticals.
    Salib NN; El-menshaway ME; Ismail AA
    Pharmazie; 1976; 31(10):721-3. PubMed ID: 1019195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scleroglucan: a versatile polysaccharide for modified drug delivery.
    Coviello T; Palleschi A; Grassi M; Matricardi P; Bocchinfuso G; Alhaique F
    Molecules; 2005 Jan; 10(1):6-33. PubMed ID: 18007275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Release kinetics of drug from different combined ratios of micropellets.
    Lin SY
    J Microencapsul; 1993; 10(3):319-22. PubMed ID: 8377089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral sustained delivery of theophylline from thermally reversible xyloglucan gels in rabbits.
    Miyazaki S; Kawasaki N; Endo K; Attwood D
    J Pharm Pharmacol; 2001 Sep; 53(9):1185-91. PubMed ID: 11578100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral controlled release preparations.
    García CR; Siqueiros A; Benet LZ
    Pharm Acta Helv; 1978; 53(3-4):99-109. PubMed ID: 360228
    [No Abstract]   [Full Text] [Related]  

  • 38. [Oral treatment, some points to consider].
    Duquet N
    J Pharm Belg; 2010 Dec; (4):93-9. PubMed ID: 21294314
    [No Abstract]   [Full Text] [Related]  

  • 39. Sustained-release dosage forms.
    Geraets D; Burke T
    Iowa Med; 1990 Feb; 80(2):90-4. PubMed ID: 2307573
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro evaluation of micronized low-substituted hydroxypropylcellulose as an insoluble swellable matrix for sustained-release tablets.
    Nakagami H; Nada M
    Drug Des Discov; 1991 Dec; 8(2):103-16. PubMed ID: 1793773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.